Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial

被引:0
|
作者
Mueller, Lorenz [1 ,2 ]
de Jesus, Joyce Santos [1 ,2 ]
Schmid, Yasmin [1 ,2 ]
Mueller, Felix [1 ,2 ,3 ]
Becker, Anna [1 ,2 ]
Klaiber, Aaron [1 ,2 ]
Straumann, Isabelle [1 ,2 ]
Luethi, Dino [1 ,2 ,4 ]
Haijen, Eline C. H. M. [5 ]
Hurks, Petra P. M. [5 ]
Kuypers, Kim P. C. [5 ]
Liechti, Matthias E. [1 ,2 ,4 ]
机构
[1] Univ Hosp Basel, Div Clin Pharmacol & Toxicol, Schanzenstr 55, CH-4031 Basel, Switzerland
[2] Univ Basel, Dept Clin Res, Basel, Switzerland
[3] Univ Psychiat Clin Basel, Basel, Switzerland
[4] Univ Basel, Dept Biomed, Basel, Switzerland
[5] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands
关键词
MICRODOSING PSYCHEDELICS; TOLERABILITY; DISORDER; METHYLPHENIDATE; VALIDATION; STATES;
D O I
10.1001/jamapsychiatry.2025.0044
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Importance Microdosing psychedelics, including lysergic acid diethylamide (LSD), has gained attention for its potential benefits in several psychiatric disorders, including attention-deficit/hyperactivity disorder (ADHD). However, LSD's efficacy in reducing ADHD symptoms remains unknown. Objective To determine the safety and efficacy of repeated low doses of LSD in reducing ADHD symptoms compared with placebo. Design, Setting, and Participants This was a 6-week, multicenter, double-blind, placebo-controlled, parallel-group phase 2A randomized clinical trial conducted between December 17, 2021, and December 4, 2023. Data were analyzed from March 22, 2024, to August 19, 2024. Outpatient treatment was provided at 2 centers: University Hospital in Basel, Switzerland, and Maastricht University in the Netherlands. Adults aged 18 to 65 years with a prior ADHD diagnosis who presented with moderate to severe symptoms (Adult Investigator Symptom Rating Scale [AISRS] score >= 26 and Clinical Global Impression Severity score >= 4) were eligible for inclusion. Key exclusion criteria included selected current major psychiatric or somatic disorders and the use of potentially interacting medications. Intervention Participants received either LSD (20 mu g) or placebo twice weekly for 6 weeks (total of 12 doses). Main Outcome and Measures The primary outcome was the change in ADHD symptoms from baseline to week 6, assessed by the AISRS and analyzed with a mixed-effects model for repeated measures. Results A total of 53 participants were randomized to LSD (n = 27) or placebo (n = 26). Mean (SD) participant age was 37 (12) years, and 22 participants (42%) were female. The LSD group presented a mean AISRS improvement of -7.1 points (95% CI, -10.1 to -4.0). The placebo group presented a mean AISRS improvement of -8.9 points (95% CI, -12.0 to -5.8), with no difference between groups. LSD was physically safe and psychologically well tolerated overall. Conclusions and Relevance In this randomized clinical trial, repeated low-dose LSD administration was safe in an outpatient setting, but it was not more efficacious than placebo in reducing ADHD symptoms. Trial Registration ClinicalTrials.gov Identifier: NCT05200936
引用
收藏
页数:8
相关论文
共 50 条
  • [21] SAFETY AND EFFICACY OF REPEATED LOW-DOSE STREPTOKINASE INFUSIONS FOR DECLOTTING HEMODIALYSIS SUBCLAVIAN CATHETERS
    WELIK, R
    JOSSELSON, J
    SHEN, S
    REED, W
    SADLER, J
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1985, 6 (06) : A23 - A23
  • [22] Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
    Huss, Michael
    Duhan, Praveen
    Gandhi, Preetam
    Chen, Chien-Wei
    Spannhuth, Carsten
    Kumar, Vinod
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 1741 - 1751
  • [23] Comparison of the efficacy and safety of amisulpride versus low-dose amisulpride plus low-dose sulpiride in treatment of schizophrenia
    Lin, S. C.
    Wang, F. C.
    Huang, Y. H.
    Lin, C. H.
    Chen, C. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S489 - S490
  • [24] Safety and efficacy of low-dose esketamine in laparoscopic cholecystectomy: a prospective, double-blind randomized controlled trial
    Zhao, Lu
    Li, Zhengyu
    Jin, Bi
    Hou, Nina
    Yang, Heng
    BMC ANESTHESIOLOGY, 2024, 24 (01)
  • [25] Efficacy and safety of low-dose aspirin on preventing transplant renal artery stenosis: a prospective randomized controlled trial
    Tian, Xiangyong
    Ji, Bingqing
    Niu, Xiaoge
    Duan, Wenjing
    Wu, Xiaoqiang
    Cao, Guanghui
    Zhang, Chan
    Zhao, Jingge
    Wang, Zhiwei
    Gu, Yue
    Cao, Huixia
    Qin, Tao
    Shao, Fengmin
    Yan, Tianzhong
    CHINESE MEDICAL JOURNAL, 2023, 136 (05) : 541 - 549
  • [26] Efficacy and safety of low-dose aspirin on preventing transplant renal artery stenosis: a prospective randomized controlled trial
    Tian Xiangyong
    Ji Bingqing
    Niu Xiaoge
    Duan Wenjing
    Wu Xiaoqiang
    Cao Guanghui
    Zhang Chan
    Zhao Jingge
    Wang Zhiwei
    Gu Yue
    Cao Huixia
    Qin Tao
    Shao Fengmin
    Yan Tianzhong
    中华医学杂志英文版, 2023, 136 (05)
  • [27] Safety and efficacy of low-dose esketamine in laparoscopic cholecystectomy: a prospective, double-blind randomized controlled trial
    Lu Zhao
    Zhengyu Li
    Bi Jin
    Nina Hou
    Heng Yang
    BMC Anesthesiology, 24
  • [28] Safety and efficacy of low-dose MgSO4 in the treatment of eclampsia
    Shilva
    Saha, S. C.
    Kalra, J.
    Prasad, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2007, 97 (02) : 150 - 151
  • [29] Efficacy of low-dose rituximab for the treatment of refractory autoimmune cytopenias in adults
    Wandroo, F. A.
    Bokhari, S. W.
    Chapman, O.
    Muddana, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 : 33 - 33
  • [30] Efficacy and Safety of Tirofiban with Low-Dose Heparin in the Treatment of Progressing Stroke
    Mu, F. Q.
    Chen, T.
    Liu, S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 : S330 - S330